Carrier Test Page
Save your life & Next Generation.
Congenital Disorder of Glycosylation: Type Ib
What is Congenital Disorder of Glycosylation: Type Ib?
Congenital disorder of glycosylation (CDG) is a group of inherited disorders caused by defects in glycosylation, the process of attaching sugars to proteins and lipids. CDG type Ib, which is also called MPI-CDG, is due to reduced activity of an enzyme called phosphomannose isomerase. CDG-Ib is distinct from most other CDGs in two ways. First, CDG-Ib does not significantly affect the central nervous system. Second, this potentially fatal disorder can be treated. CDG-Ib affects the liver and the gastrointestinal tract. Infants with CDG-Ib present with chronic diarrhea, recurring vomiting, liver problems, low blood sugar, and malnutrition. Severity is variable among affected individuals. CDG-Ib can be treated effectively by lifelong dietary supplements of a particular sugar known as mannose. CDG-Ib is caused by pathogenic variants in the gene MPI.
How is Congenital Disorder of Glycosylation: Type Ib inherited?
CDG-Ib is inherited in an autosomal recessive manner. This type of inheritance requires the presence of two copies of a pathogenic variant in the gene for a person to have the genetic disease. Both parents must be carriers of a pathogenic variant in the gene in order to be at risk to have an affected child. The child must inherit a pathogenic variant from each carrier parent in order to be affected. There is a 1 in 4 chance that a baby will inherit two mutated copies of the gene and be affected when both parents are carriers.
What does it mean to be a carrier?
There are generally no signs or symptoms associated with being a carrier for CDG-Ib. However, the risk to have a child affected with CDG-Ib is increased. Testing of reproductive partners is recommended for carriers of CDG-Ib.
How common is Congenital Disorder of Glycosylation: Type Ib?
What is analysed?
|Ethnicity||Detection Rate||Carrier Frequency|
|General Population||94%||1 in 500|